Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Myriad Genetics Inc MYGN

Healthcare Biotechnology
Myriad Genetics, Inc. is a genetic testing and precision medicine company. The Company develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. The Company is focused on three key areas where it has... see more

Recent & Breaking News (NDAQ:MYGN)

Myriad Appoints Chip Parkinson as EVP for Reimbursement Strategy

GlobeNewswire September 29, 2016

Myriad to Present New myRisk Hereditary Cancer Data Further Demonstrating the Benefits of Gene Panel Testing

GlobeNewswire September 26, 2016

Services Stocks on Investors' Radar -- HERC, Myriad Genetics, Qiagen, and INC Research

PR Newswire September 21, 2016

Myriad RBM’s TruCulture® and Gene Expression Profiling Characterizes Immune Responses in Landmark Study Led by Institut Pasteur

GlobeNewswire September 7, 2016

Myriad Genetics Completes Acquisition of Assurex Health

GlobeNewswire September 1, 2016

Myriad Genetics to Present at the 2016 Morgan Stanley Global Healthcare Conference

GlobeNewswire August 30, 2016

Wednesday's Market Wrap: U.S. Stocks Trend Lower Mid-Week

Benzinga.com  August 10, 2016

Mid-Afternoon Market Update: Dow Falls 50 Points; Myriad Genetics Shares Decline Following Downbeat Results

Benzinga.com  August 10, 2016

20 Biggest Mid-Day Losers For Wednesday

Benzinga.com  August 10, 2016

Mid-Day Market Update: Crude Oil Down 2%; Clean Energy Fuels Shares Climb Following Upbeat Earnings

Benzinga.com  August 10, 2016

Mid-Morning Market Update: Markets Mostly Lower; Michael Kors Issues Downbeat Guidance

Benzinga.com  August 10, 2016

22 Stocks Moving In Wednesday's Pre-Market Session

Benzinga.com  August 10, 2016

Myriad Genetics Weak Guidance Drives Shares Down 20%

Benzinga.com  August 9, 2016

Myriad Genetics Reports Fiscal Fourth-Quarter 2016 Financial Results

GlobeNewswire August 9, 2016

Myriad Genetics Signs Definitive Agreement to Acquire Assurex Health

GlobeNewswire August 3, 2016

Myriad to Announce Fiscal Fourth-Quarter 2016 Financial Results on August 9

GlobeNewswire July 26, 2016

Myriad Announces Positive Results for an EndoPredict® Clinical Study Published in the Journal of the National Cancer Institute

GlobeNewswire July 11, 2016

Myriad’s myChoice® HRD Test Successfully Identifies Patients that Meet Primary Endpoint in TESARO’s Pivotal Phase 3 Ovarian Cancer Study with Niraparib

GlobeNewswire June 29, 2016

Active Equities to Watch in the Services Sector -- Booz Allen Hamilton Holding, Qiagen, INC Research Holdings, and Myriad Genetics

PR Newswire June 17, 2016

Crescendo Bioscience Announces that New Data on Vectra® DA Will Be Presented at the European League Against Rheumatism 17th Annual Congress

GlobeNewswire June 10, 2016
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse
Later
Participate
Not interested